British 7.7495933
ĠBi 9.123531
otech 3.242978
Ġpl 8.414039
c 0.0039677243
's 4.8641224
Ġcancer 8.362692
Ġdrug 1.2563425
ĠMar 7.7839937
im 4.9183397
ast 6.2603636
at 3.520215
ĠShows 11.873411
ĠPromise 1.9408754
, 2.7807348
ĠBut 2.3403337
ĠFaces 6.1791525
ĠH 5.2994485
urd 0.14190708
les 0.16848405
Ġto 3.5541327
ĠBecome 8.1345005
Ġa 1.0505593
ĠBlock 7.2274284
buster 0.011523551
ĠBritish 8.024208
ĠBi 0.24465175
otech 0.0038508032
Ġpl 0.23957168
c 0.00039544783
Ġannounced 4.0995574
Ġpromising 8.661175
Ġresults 0.2595472
Ġfor 2.9242518
Ġits 0.79163027
Ġcancer 1.7581906
Ġdrug 0.14300123
, 1.9609907
ĠMar 0.21156755
im 0.0016419195
ast 0.00728733
at 0.00065230025
, 0.15951492
Ġwhich 3.0715835
Ġtargets 4.6623125
Ġthe 1.4708469
Ġfast 6.8883677
- 0.12651294
growing 0.21646309
Ġmatrix 10.756806
Ġmet 0.8498591
all 0.043183006
op 0.05077497
rotein 0.044143755
ase 0.2975244
Ġ( 1.4756746
M 0.15043364
MP 0.013163307
) 0.35749164
Ġmarket 13.512944
. 0.77575886
ĠThe 1.6163956
Ġdrug 2.0143645
Ġis 1.8234272
Ġdesigned 3.946311
Ġto 0.07078566
Ġinhibit 3.5423443
Ġthe 0.90899473
Ġactivity 2.945306
Ġof 0.01301004
Ġspecific 6.712315
ĠM 0.73545873
MP 0.0012314853
s 0.4637263
Ġthat 2.8450127
Ġpromote 3.328081
Ġthe 2.012858
Ġgrowth 0.37715575
Ġand 2.2327666
Ġspread 1.4877939
Ġof 0.0019240561
Ġcancer 0.44996977
Ġcells 0.8552622
. 0.5147844
ĠThe 1.5865637
Ġdrug 1.6210257
Ġis 1.4153081
Ġcurrently 2.1375115
Ġin 1.075363
ĠPhase 1.2467823
ĠIII 2.034594
Ġclinical 0.7303296
Ġtrials 0.31553724
, 1.8829359
Ġand 1.2173393
Ġresults 5.080292
Ġfrom 1.3113607
Ġa 3.6188922
Ġrecent 3.502755
Ġtrial 3.3240433
Ġdemonstrate 6.7098274
Ġthe 2.9939868
Ġdrug 1.5162256
's 0.83046997
Ġpotential 1.9222034
Ġas 2.2693548
Ġa 0.19550642
Ġtherapeutic 3.9384456
Ġoption 1.7291778
Ġfor 0.6137904
Ġcancer 2.5028746
Ġpatients 0.5887749
. 0.49125734
ĠMar 3.4699333
im 0.00060738955
ast 0.0007163003
at 0.00024692412
Ġhas 2.2815611
Ġbeen 1.5556256
Ġproven 6.4587865
Ġto 0.6695664
Ġbe 1.4077885
Ġeffective 1.4113561
Ġagainst 1.9450868
Ġa 2.0372744
Ġwide 2.6343799
Ġrange 0.6260964
Ġof 0.0025441386
Ġcancers 1.4116968
, 0.56597227
Ġincluding 0.42651746
Ġpancreat 3.0935717
ic 0.0033304922
Ġcancer 1.523693
, 0.36137772
Ġcol 3.005199
ore 0.002766818
ct 0.0010897613
al 0.002219652
Ġcancer 0.044741966
, 0.17844704
Ġand 1.8236428
Ġmetast 5.55008
atic 0.051240638
Ġmelan 1.0857571
oma 0.013110162
. 0.26016524
ĠThe 1.721896
Ġdrug 0.7887244
Ġinhibits 6.384901
Ġthe 0.97428507
Ġactivity 1.3909407
Ġof 0.009349061
ĠM 0.82123065
MP 0.00046014716
s 0.64731765
, 1.6790103
Ġwhich 1.0655104
Ġplay 3.0419598
Ġcritical 4.8437505
Ġroles 0.016064215
Ġin 0.026696408
Ġmany 4.282291
Ġphysiological 6.006296
Ġprocesses 0.40279344
, 1.3483542
Ġsuch 1.5746001
Ġas 0.005342464
Ġtissue 3.2989292
Ġremod 2.4824116
eling 0.058637083
, 0.7058905
Ġwound 3.99981
Ġhealing 0.15029654
, 0.11521791
Ġand 0.8354421
Ġtumor 4.030912
Ġinvasion 3.5467887
. 0.19844724
ĠWhen 6.143389
ĠM 3.8475857
MP 0.0007839423
s 0.20160352
Ġare 0.37218013
Ġover 3.0323992
activated 3.5638113
, 0.20892209
Ġas 5.924992
Ġin 1.8908312
Ġcancer 0.6209055
, 0.48802152
Ġthey 1.167642
Ġpromote 2.0167758
Ġthe 0.9561893
Ġgrowth 0.28206027
Ġand 0.6760005
Ġspread 0.11271824
Ġof 0.0032190236
Ġcancer 0.620349
Ġcells 0.10934828
Ġby 3.4321516
Ġdegrading 4.968661
Ġthe 2.1752455
Ġext 2.4346428
race 0.00069434993
llular 3.583558e-05
Ġmatrix 0.009220078
Ġ( 1.3306146
EC 0.024198515
M 0.0036291375
) 0.7805628
Ġsurrounding 2.7200308
Ġthe 1.0450878
Ġtumor 1.9661024
. 0.4717421
ĠThe 1.7249972
ĠPhase 7.918081
ĠIII 0.1627747
Ġclinical 1.8784859
Ġtrial 0.24962643
Ġconducted 3.2994542
Ġby 0.57885987
ĠBritish 2.2104974
ĠBi 0.022017065
otech 0.0013484035
Ġpl 2.1457222
c 0.00045120085
Ġdemonstrated 3.0749907
Ġthat 0.39988133
ĠMar 0.95176405
im 0.0003244323
ast 0.00070150715
at 0.00021383668
Ġcan 3.4039297
Ġsignificantly 3.1124396
Ġimprove 2.754736
Ġthe 0.90503687
Ġprogression 4.4170012
- 1.9448464
free 0.020536616
Ġsurvival 0.027615512
Ġrate 1.6564866
Ġof 0.6315381
Ġpatients 0.53272617
Ġwith 0.32597318
Ġadvanced 1.3720212
Ġpancreat 3.1840134
ic 0.0009554553
Ġcancer 0.09550834
. 1.0224961
ĠIn 2.4566472
Ġthe 1.4996057
Ġtrial 1.1355525
, 0.07749331
Ġpatients 1.5218738
Ġwho 2.1470025
Ġreceived 0.51780975
ĠMar 1.4906343
im 0.0005119672
ast 0.00063100696
at 0.00034858286
Ġhad 1.2669866
Ġa 0.53301626
Ġmedian 2.2677238
Ġprogression 3.028392
- 0.12740408
free 0.00073151017
Ġsurvival 0.0024597032
Ġrate 1.7059971
Ġof 0.0775098
Ġ2 5.350284
. 0.03291688
3 2.3038769
Ġmonths 0.49843317
, 1.3316458
Ġcompared 0.6802177
Ġto 0.3467957
Ġ1 2.006805
. 0.0071256524
6 2.1493146
Ġmonths 0.06837856
Ġfor 1.1542395
Ġpatients 1.0637015
Ġwho 0.39282674
Ġreceived 0.70508957
Ġthe 2.7025244
Ġplacebo 1.7519281
. 0.31578505
ĠThe 1.2943944
Ġdrug 2.3893676
Ġshowed 3.9305878
Ġsimilar 2.907969
Ġpromising 6.852427
Ġresults 0.13383898
Ġin 0.4021715
Ġthe 1.7531298
Ġtreatment 3.5881774
Ġof 0.020887064
Ġother 3.598374
Ġcancers 2.3698325
Ġas 3.8466437
Ġwell 0.019337302
. 0.65942043
ĠHowever 5.315599
, 0.004748492
Ġdespite 4.805481
ĠMar 4.1096115
im 0.0004371277
ast 0.0006713868
at 0.0003506094
's 0.18891568
Ġpotential 3.2020316
Ġto 1.4448167
Ġbecome 6.438562
Ġa 0.2118946
Ġblockbuster 0.6068871
Ġdrug 0.5961666
, 0.33825678
Ġthere 2.509415
Ġare 0.31360066
Ġsignificant 2.8410192
Ġhurdles 1.7399943
Ġthat 1.9657019
ĠBritish 2.8633454
ĠBi 0.013614558
otech 0.00053492666
Ġpl 0.29347593
c 0.00025324314
Ġwill 1.5229174
Ġhave 0.7517847
Ġto 0.0046009957
Ġovercome 0.12520109
. 3.5262802
ĠFirstly 4.897228
, 0.0074398424
Ġthe 0.8676949
Ġdrug 0.4834744
's 2.0440106
Ġpatent 4.9841104
Ġprotection 1.7079049
Ġhas 3.4531393
Ġexpired 1.3771056
, 0.78696644
Ġwhich 2.1740074
Ġmeans 0.7551081
Ġthat 0.5120704
Ġthe 2.0310214
Ġdrug 0.975777
Ġis 1.712703
Ġnow 2.695851
Ġavailable 1.6399463
Ġas 4.2601743
Ġa 0.48771685
Ġgeneric 0.57434744
Ġdrug 1.0774907
. 0.8203614
ĠThis 2.3123612
Ġwill 2.8229373
Ġmake 2.9734464
Ġit 0.4834748
Ġdifficult 1.404497
Ġfor 0.35903823
ĠBritish 1.6454538
ĠBi 0.010923065
otech 0.00024597047
Ġpl 0.1705457
c 0.00082695123
Ġto 0.036127526
Ġgenerate 4.5202274
Ġsignificant 2.9914918
Ġrevenue 1.1438144
Ġfrom 0.4966799
Ġthe 0.5803745
Ġdrug 0.32933506
. 0.80185205
ĠSecondly 0.5590782
, 0.00241095
Ġthe 0.8561607
Ġcompany 2.8253124
Ġwill 1.8807366
Ġneed 1.4182277
Ġto 0.047908742
Ġdemonstrate 4.1751075
Ġthe 2.3466725
Ġdrug 0.95166665
's 0.12206412
Ġsafety 1.0995836
Ġand 0.76232696
Ġefficacy 0.28073338
Ġthrough 4.002846
Ġfurther 4.880842
Ġclinical 0.97896504
Ġtrials 0.21791928
. 0.839424
ĠWhile 3.6360056
Ġthe 1.0498359
Ġresults 3.5748718
Ġfrom 1.2545011
Ġthe 0.93127894
ĠPhase 0.47144255
ĠIII 0.09161945
Ġclinical 1.1610217
Ġtrial 0.10254668
Ġare 1.3485453
Ġpromising 0.7201259
, 0.075150035
Ġthey 3.1955762
Ġwill 1.9665034
Ġneed 2.386904
Ġto 0.065332636
Ġbe 0.16528419
Ġreplicated 1.9908929
Ġin 0.50325114
Ġlarger 1.8153088
- 3.175004
scale 0.010079124
Ġtrials 1.3932425
Ġto 1.3438194
Ġensure 2.0669293
Ġthat 0.68702024
Ġthe 0.509118
Ġdrug 0.13826182
Ġis 0.9426511
Ġsafe 0.35084525
Ġand 0.25783145
Ġeffective 0.24434206
Ġfor 1.6489228
Ġa 3.5171788
Ġwider 2.7728992
Ġrange 1.5823952
Ġof 0.001225398
Ġpatients 0.7592511
. 0.12946372
ĠThird 1.8564538
ly 0.28316227
, 0.005844396
ĠMar 3.2783086
im 0.00038149662
ast 0.000686118
at 9.21049e-05
Ġfaces 4.93399
Ġcompetition 4.8387613
Ġfrom 0.1341586
Ġother 1.6260836
ĠM 3.581829
MP 0.0009029538
Ġinhibitors 0.1298262
Ġcurrently 3.1895895
Ġin 1.1190933
Ġdevelopment 1.1056832
. 0.7758817
ĠSeveral 4.473138
Ġother 2.409687
Ġpharmaceutical 5.193369
Ġcompanies 0.11521369
Ġare 1.0581492
Ġdeveloping 1.2651879
ĠM 0.9803244
MP 0.00093212794
Ġinhibitors 0.078859486
Ġto 2.165591
Ġtarget 2.2002428
Ġcancer 2.5498922
, 1.8306316
Ġsuch 2.6341805
Ġas 0.01386546
ĠGl 5.1344304
ax 0.6412081
o 0.01790474
Smith 0.05231569
K 0.012543006
line 0.005447335
Ġpl 2.6918085
c 0.00013109177
's 0.10962373
ĠB 5.6080484
MS 1.2662361
- 1.1399137
275 6.7314367
291 8.918108
Ġand 0.9021787
ĠMillennium 8.940105
ĠPharmaceutical 0.6008619
s 0.11958654
ĠInc 3.7600498
.' 1.0974965
s 0.00043259587
Ġ( 4.18739
now 5.14274
ĠT 5.453484
aked 0.048993826
a 0.008590737
ĠPharmaceutical 0.61594224
ĠCo 1.5838847
. 1.6222107
ĠLtd 0.18028936
.) 0.3231826
ĠPrin 12.301889
om 6.484204
ast 1.4188279
at 0.06572085
. 0.4231566
ĠThis 4.8874655
Ġmeans 3.648803
Ġthat 0.04664927
ĠBritish 1.7757692
ĠBi 0.005080867
otech 0.00061705016
Ġpl 0.05628123
c 0.0030045516
Ġwill 0.42082924
Ġneed 1.215038
Ġto 0.0139809
Ġwork 3.1405997
Ġhard 1.7920375
Ġto 0.06760296
Ġdifferentiate 4.53656
ĠMar 2.869263
im 0.00024811528
ast 0.00048083876
at 9.687513e-05
Ġfrom 0.33913893
Ġits 2.1158535
Ġcompetitors 0.2593214
Ġand 2.7539833
Ġposition 5.925103
Ġit 1.7585684
Ġas 0.56441313
Ġthe 1.8350862
Ġmost 3.0479982
Ġeffective 1.4290352
ĠM 0.6791061
MP 0.0004136351
Ġinhibitor 0.02677293
. 2.1745408
ĠBritish 4.5212245
ĠBi 0.008112667
otech 0.00047064314
Ġpl 0.031828232
c 0.00029998703
Ġwill 2.1061954
Ġneed 2.1405678
Ġto 0.02384184
Ġinvest 4.6084814
Ġin 1.2267354
Ġmarketing 3.657658
Ġand 1.2003343
Ġresearch 2.371702
Ġand 2.0281308
Ġdevelopment 0.07004867
Ġto 0.9630198
Ġensure 1.2741863
Ġthat 0.14645763
ĠMar 1.4498588
im 8.197403e-05
ast 0.00041482816
at 7.302963e-05
Ġbecomes 2.6299305
Ġa 0.41007814
Ġblockbuster 0.5388305
Ġdrug 0.23722084
. 0.69533503
ĠThe 2.4719255
Ġcompany 0.5737643
Ġwill 1.2844808
Ġneed 1.4317758
Ġto 0.022563282
Ġconduct 5.642714
Ġfurther 2.769031
Ġtrials 2.1969495
Ġto 0.6497127
Ġdemonstrate 3.0550168
Ġthe 1.0711191
Ġdrug 0.37185258
's 0.020566614
Ġsafety 0.60207146
Ġand 0.06830242
Ġefficacy 0.15167587
Ġand 2.3472342
Ġto 1.6922897
Ġdetermine 2.9475453
Ġthe 1.2436918
Ġoptimal 2.1209462
Ġdose 1.5931517
Ġand 1.5739752
Ġtreatment 4.7585254
Ġfor 3.328031
Ġeach 1.0878828
Ġcancer 3.721447
Ġtype 2.232731
. 0.29011762
ĠAdditionally 4.886623
, 0.004031819
Ġthe 1.0347939
Ġcompany 0.70671535
Ġwill 0.22421862
Ġneed 0.34023893
Ġto 0.0074592386
Ġdevelop 2.3413548
Ġstrong 6.4232054
Ġpartnerships 1.6679668
Ġwith 0.21323444
Ġphysicians 4.8912926
, 1.6087296
Ġhospitals 1.4201784
, 0.12633559
Ġand 0.5473453
Ġother 1.637073
Ġstakeholders 5.1814804
Ġto 0.8486819
Ġensure 0.8505057
Ġthat 0.14578037
ĠMar 2.1057086
im 0.00019404522
ast 0.0004160193
at 0.00010486492
Ġis 0.83404475
Ġwidely 4.1564183
Ġprescribed 4.486654
Ġand 0.8672459
Ġused 1.9989189
Ġin 1.4875188
Ġthe 1.2423958
Ġtreatment 1.7248522
Ġof 0.031081352
Ġcancer 0.5815955
. 0.50644666
ĠDespite 5.3947515
Ġthe 1.291325
Ġchallenges 1.0393523
, 1.5317538
ĠMar 2.4882274
im 0.0003274144
ast 0.0010233489
at 0.00014003337
's 2.0983915
Ġpotential 1.7496588
Ġto 2.0097265
Ġbecome 0.28455067
Ġa 0.06795856
Ġblockbuster 0.12346656
Ġdrug 0.06676309
Ġis 0.9339454
Ġsignificant 3.8290966
. 0.72401637
ĠThe 1.8116578
Ġdrug 1.025425
Ġhas 1.6467419
Ġdemonstrated 3.0036879
Ġpromising 1.4049339
Ġresults 0.18929684
Ġin 0.66216934
ĠPhase 2.4548
ĠIII 0.078349195
Ġclinical 0.31960046
Ġtrials 0.05406771
Ġand 1.4000841
Ġhas 2.084953
Ġthe 2.2639337
Ġpotential 0.10081761
Ġto 0.03514722
Ġbecome 1.0493784
Ġa 0.21358867
Ġvaluable 4.0427084
Ġtherapeutic 2.5914102
Ġoption 0.11240972
Ġfor 0.24982536
Ġcancer 0.8256517
Ġpatients 0.030286908
. 0.19269016
ĠBritish 2.5119758
ĠBi 0.0066862046
otech 0.0018260019
Ġpl 0.02059162
c 0.012409623
Ġmust 7.262939
Ġwork 2.4920807
Ġhard 0.90808755
Ġto 0.08649907
Ġovercome 3.8324916
Ġthe 1.2228158
Ġhurdles 1.9659519
Ġand 1.6684041
Ġposition 5.1465826
ĠMar 0.8142485
im 0.00018307802
ast 0.000549242
at 9.139247e-05
Ġas 0.10248375
Ġthe 0.81586176
Ġmost 0.5067527
Ġeffective 0.047062397
ĠM 0.090819225
MP 0.0004595511
Ġinhibitor 0.004596744
Ġon 4.4054914
Ġthe 0.008793839
Ġmarket 0.0338202
. 0.25047904
ĠWith 4.9924407
Ġthe 1.2170227
Ġright 4.189402
Ġinvestment 3.7989793
Ġand 1.0329868
Ġstrategy 2.2821002
, 0.064124055
ĠMar 1.9734657
im 0.00015923065
ast 0.00068432797
at 9.0795475e-05
Ġcould 0.8166502
Ġbecome 0.5590023
Ġa 0.3206888
Ġkey 5.9626203
Ġplayer 1.2136755
Ġin 0.05640666
Ġthe 0.0889608
Ġfight 5.538598
Ġagainst 0.033552784
Ġcancer 0.14510687
. 0.28451732
